The round was led by CVS Health Ventures with participation from Cobalt Ventures, and follow-on investments from Seed investors F-Prime, Frist Cressey and Autism Impact Fund. Financing will accelerate adoption of SpectrumAi's applied behavior analysis (ABA) electronic health record, Twyll, and Patterns, its network analytics platform, that are designed to improve data capture and objective measurement of ABA therapy for autism.

SpectrumAi develops innovative solutions to improve life-changing therapies. SpectrumAi's initial focus is to modernize Applied Behavior Analysis (ABA) for children with autism by capturing and measuring objective treatment and outcomes data to understand quality drivers.